Shows
NeurologyLive® Mind Moments®Raising Epilepsy Awareness for Purple DayWelcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, Sonal Bhatia, MD, FACNS, epilepsy expert and director of the pediatric epilepsy monitoring unit (EMU) at the Medical University of South Carolina, discussed Purple Day, celebrated on March 25th, and the importance of raising awareness for patients with epilepsy, a common condition affecting one in 26 individuals. She discussed the stigma faced by patients with epilepsy, especially in parts of the world outside the United States. Bhatia also discussed some of the recent ad...2025-03-0724 min
The Collective Corner with Elena Armijo059: Blending Science and Spirituality for Holistic HealthIn this episode, Elena Armijo sits down with Dr. Sonal Bhatia, a physician and former Pfizer executive, who is on an inspiring journey from the confines of Western medicine to a more holistic, integrated approach to health. With roots in Mexico City and a rich Indian heritage, Sonal’s unique background informs her mission to activate the inner healing intelligence within each person, blending the best of Eastern and Western practices. Check out Elena’s website to learn more about how she can support you in seeing and using the power that resides within you. Dr...2025-02-2640 min
RARECastHow One Drugmaker Reaches out to Communities at Greater Risk for Rare Heart ConditionTransthyretin amyloid cardiomyopathy, or ATTR-CM, is a progressive and potentially fatal heart disease. It is often overlooked because physicians tend to consider more common causes of heart failure. We spoke to Pfizer Vice President and North America Medical Lead Younos Abdulsattar and Pfizer Chief Medical Officer of Rare Disease Sonal Bhatia, about ATTR-CM; its disproportionate impact on the Black, African American, and Afro-Caribbean communities; and steps Pfizer is taking to work with community organizations to raise awareness and improve care for people with the condition.2023-03-0315 min
Evincepub Publishing PodcastEP10: Sea Through My Eyes: An Untold Saga of a Seafarer by Sonal BhatiaCheck out our latest episode!Sea Through My Eyes: An Untold Saga of a Seafarer"I married a sailor to put an end to my spinsterhood, but it was not an ordinary marital knot. On marrying him came along isolation, distance, pain, sacrifices and unconditional love.I bid him a safe voyage every time and waited days and months for his safe homecomings. Juggling with dual responsibilities of the family, maintaining the symbolic status of being a sailor’s wife, I take pride in the applets on...2022-02-1204 min
Science Will WinBONUS – Into the Pfizer Lab: Making a Gene TherapyIn this special bonus episode, Adam Rutherford explores a different aspect of gene therapy - how do you actually make one? Expert guests discuss the highly complex task of scaling-up manufacturing from the small amounts needed for research, to creating batches big enough for clinical and commercial scale. And once that hurdle has been cleared, how do they address the additional challenge of storing and transporting the medicine at ultra-low temperatures?Featuring guests:Bert Bruce, Regional President, North America, Rare Disease, PfizerBob Smith, Senior Vice President, Global Gene Therapy Business, Rare Disease, Pfizer Son...2021-12-1014 min
Science Will WinGene Therapy – Behind the ScienceGene therapy is a revolutionary field of science that has the potential to transform lives. It presents this big question; What if we could treat a disease at its root cause, rather than just the symptoms? On the first episode of Science Will Win, host Adam Rutherford takes us through the history, science, and significance of gene therapy.Featuring guests:Dirk Vander Mijnsbrugge, Vice President, Medical Affairs, Rare Diseases, PfizerDurhane Wong-Rieger, President & CEO at Canadian Organization for Rare DisordersLaurence Woollard, Director, On The Pulse ConsultancySonal Bhatia, Chief Medical Officer...2021-10-0825 min
16 Minutes News by a16zA Faster, Cheaper Test -- Will It Really Democratize Coronavirus Testing?In this episode of 16 Minutes, we cover the recent news around the FDA's Emergency Use Authorization approval of Abbott Lab's latest COVID-19 test, which takes 15 minutes and will cost $5. At that speed and price point -- as well as the fact that it doesn't require lab equipment at point of care -- it should definitely increase testing capacity, making it a potential "game changer" in this pandemic... But does it truly democratize coronavirus testing (in an available-to-everyone-everywhere way)? How is and isn't it like a pregnancy test, and when or how would we be able to administer it everywhere...2020-09-0217 min